Policy and reports

In this section of the website, policy documents issued by BBIA and others can be found alongside the many reports and studies issued by third parties that we believe are relevant to the bioeconomy.

Clear
Concepts: Biobased

Concepts: Biobased

Concepts Biobased: Unmatched insight and analysis into the innovations shaping the global textile value chain.

Rethinking Beauty Packaging: Beyond Recycling to True Sustainability

Rethinking Beauty Packaging: Beyond Recycling to True Sustainability

New report from BBIA and Cosmetics Cluster UK sets out how bio-based materials, innovative packaging design and smarter regulation could transform the sustainability of the UK beauty industry.

UK Bio35: Biology, Engineered for Growth

UK Bio35: Biology, Engineered for Growth

UKBio35 sets out the BBIA’s vision for achieving this outcome by 2035. It defines how BBIA will act as a strategic systems leader – bringing together industry, government, investors, regulators, researchers and civil society to create the conditions needed for bio-based innovation to thrive.

National Plan for Industrial Biotechnology

National Plan for Industrial Biotechnology

Scotland’s refreshed National Plan for Industrial Biotechnology sets out a clear ambition to scale bio-based manufacturing, strengthen supply chains and attract investment.

The UK’s bioeconomy: A case for building growth, resilience and  sustainability

The UK’s bioeconomy: A case for building growth, resilience and sustainability

The UK’s bioeconomy: A case for building growth, resilience and sustainability, showcases the UK’s strengths in the bioeconomy and actions needed to accelerate our transition towards a nature positive future.

BBIA Representation to Autumn Budget 2026

BBIA Representation to Autumn Budget 2026

The UK does not lack bioeconomy innovation. The challenge is turning that innovation into manufacturing, investment and jobs here in the UK. Ahead of the Autumn Budget 2026, BBIA is calling on Government to take five practical steps to help bridge the gap between world-leading UK science and industrial-scale manufacturing.

Biotech Act II (EU): Addressing cross-cutting challenges and establishing an enabling regulatory framework for industrial biotechnology and biomanufacturing

Biotech Act II (EU): Addressing cross-cutting challenges and establishing an enabling regulatory framework for industrial biotechnology and biomanufacturing

Biotech Act II (EU): Addressing cross-cutting challenges and establishing an enabling regulatory framework for industrial biotechnology and biomanufacturing

BBIA Consultation Response: UK Fertilisers Regulatory Reform (UK FPR)

BBIA Consultation Response: UK Fertilisers Regulatory Reform (UK FPR)

BBIA Consultation Response: UK Fertilisers Regulatory Reform (UK FPR)

Bio-Beauty: The Future of Engineering Biology in UK Cosmetics

Bio-Beauty: The Future of Engineering Biology in UK Cosmetics

The UK’s Modern Industrial Strategy aims to position the country as a global leader in technology-driven innovation by 2035, with engineering biology identified as a key growth sector capable of transforming industries such as beauty and personal care through sustainable, bio-based production. While the UK is well placed to lead this transition, regulatory complexity, high costs, and limited domestic supply chains are slowing progress. This report highlights the challenges and opportunities that lie ahead, and five priority actions are recommended.

UK Fermentation  & Downstream Processing Capacity: Current Capability, Scale-Up Gaps and Investment Needs for Engineering Biology in Non-Human Health Applications

UK Fermentation & Downstream Processing Capacity: Current Capability, Scale-Up Gaps and Investment Needs for Engineering Biology in Non-Human Health Applications

The UK is at a critical point in developing its engineering biology sector, with advances creating new opportunities across multiple industries. Yet a common claim persists: that limited scale-up infrastructure is the main barrier to market. This report challenges that view. Drawing on industry insights and survey data, it finds that while fermentation and downstream capacity matter, the real barriers to commercialisation are broader—spanning investment, coordination, and the link from research to industry.

Rethinking UK Packaging Policy to Unlock Bio-Based Innovation, National Resilience and Economic Growth

Rethinking UK Packaging Policy to Unlock Bio-Based Innovation, National Resilience and Economic Growth

Modern society depends on packaging to store, protect, and transport goods at scale, supporting essential systems such as food supply, healthcare, and e-commerce, while reducing damage, contamination, and waste. However, most packaging remains fossil-based and short-lived, generating significant waste and emissions; with the UK producing around 12 million tonnes annually and recycling rates still limited, policy misalignment and higher costs for bio-based alternatives risk slowing innovation, investment, and the transition to a more sustainable circular economy.

Bio-Based Solutions: Financing the Future

Bio-Based Solutions: Financing the Future

Over £3 billion has flowed into the UK bio-based sector since 2008 — but scaling the industry remains the next major challenge.

1 2 3 … 17